Bindex® technology successfully tested in osteoporosis management
‘Pulse-echo ultrasound method for detection of post-menopausal women with osteoporotic BMD’ – this is the title of a recently published international study. The study data demonstrate that a strategy of combining ultrasound measurement with added DXA measurements in cases with intermediate ultrasound results (about 30%) can be useful for identifying subjects at risk for a low bone mineral density in the osteoporotic range.
This result emphasizes the importance of the activities of Bone Index. The Finnish BFCC project partner has developed Bindex®, a tool on basis of ultrasound for osteoporosis screening and diagnostics.
CEO Ossi Riekkinen is pleased: “It was a long journey, but the team did it with a great result.” About 75% of osteoporotic patients are left undiagnosed and untreated because diagnostics are performed only at secondary care.
Read more about the study at Springer Link.
Read more about Baltic Fracture Competence Center.
20 September 2018
Bioagora 2018 (Copenhagen)
19 September 2018
STZ OcuTox: Drug development know-how
12 September 2018
Good industry performance lifted spirits in the HealthBIO conference